A Study of 48 Versus 96 Weeks of Peginterferon Alfa-2a [Pegasys] Treatment, With or Without Entecavir, in Patients With Chronic Hepatitis B.
|ClinicalTrials.gov Identifier: NCT01179594|
Recruitment Status : Withdrawn (This study was canceled for operational reasons.)
First Posted : August 11, 2010
Last Update Posted : February 17, 2017
Information provided by (Responsible Party):
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Recruitment Status :||Withdrawn|
|Estimated Primary Completion Date :||November 2014|
|Estimated Study Completion Date :||November 2014|